A.-L. Taksin

596 total citations
6 papers, 360 citations indexed

About

A.-L. Taksin is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, A.-L. Taksin has authored 6 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 2 papers in Oncology. Recurrent topics in A.-L. Taksin's work include Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Neuroblastoma Research and Treatments (1 paper). A.-L. Taksin is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Neuroblastoma Research and Treatments (1 paper). A.-L. Taksin collaborates with scholars based in France. A.-L. Taksin's co-authors include H. Farhat, Bruno Varet, Thierry de Revel, Oumédaly Reman, Ollivier Legrand, Hervé Dombret, Sylvie Chevret, Xavier Thomas, Pascal Turlure and Claude Gardin and has published in prestigious journals such as Journal of Clinical Oncology, Leukemia and Haematologica.

In The Last Decade

A.-L. Taksin

6 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.-L. Taksin France	6	219	107	106	103	71	6	360
Caterina Buquicchio Italy	7	172 0.8×	49 0.5×	62 0.6×	36 0.3×	21 0.3×	13	231
Bernard De Prijck Belgium	9	96 0.4×	68 0.6×	105 1.0×	32 0.3×	96 1.4×	24	230
Silvia Imbergamo Italy	10	83 0.4×	44 0.4×	119 1.1×	54 0.5×	62 0.9×	20	224
AC Homans United States	7	142 0.6×	74 0.7×	64 0.6×	122 1.2×	29 0.4×	12	324
Nobuaki Dobashi Japan	9	132 0.6×	104 1.0×	54 0.5×	69 0.7×	35 0.5×	50	269
Jana Mihályová Czechia	7	84 0.4×	136 1.3×	49 0.5×	90 0.9×	57 0.8×	16	251
Andrew Dalovisio United States	9	209 1.0×	188 1.8×	23 0.2×	105 1.0×	17 0.2×	17	297
Shu-Han You Taiwan	6	82 0.4×	90 0.8×	29 0.3×	53 0.5×	11 0.2×	14	301
Kathleen Glick United States	6	277 1.3×	132 1.2×	34 0.3×	116 1.1×	15 0.2×	9	377
Patti Byron United States	6	263 1.2×	129 1.2×	33 0.3×	112 1.1×	14 0.2×	8	359

Countries citing papers authored by A.-L. Taksin

Since Specialization

Citations

This map shows the geographic impact of A.-L. Taksin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-L. Taksin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-L. Taksin more than expected).

Fields of papers citing papers by A.-L. Taksin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-L. Taksin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-L. Taksin. The network helps show where A.-L. Taksin may publish in the future.

Co-authorship network of co-authors of A.-L. Taksin

This figure shows the co-authorship network connecting the top 25 collaborators of A.-L. Taksin. A scholar is included among the top collaborators of A.-L. Taksin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-L. Taksin. A.-L. Taksin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Rigaudeau, Sophie, A.-L. Taksin, N. Baron, et al.. (2016). Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy for the prediction of subsequent cardiotoxicity. Annales de Cardiologie et d Angéiologie. 65(5). 380–380. 40 indexed citations

2.

Itzykson, Raphaël, Sylvain Thépot, Odile Beyne‐Rauzy, et al.. (2011). Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?. Leukemia Research. 36(4). 397–400. 9 indexed citations

3.

Kelaïdi, Charikleia, Aspasia Stamatoullas, Odile Beyne‐Rauzy, et al.. (2009). Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies. Haematologica. 95(6). 892–899. 13 indexed citations

4.

Taksin, A.-L., Ollivier Legrand, Emmanuel Raffoux, et al.. (2006). High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group. Leukemia. 21(1). 66–71. 226 indexed citations

5.

Thomas, Xavier, Nathalie Cambier, A.-L. Taksin, et al.. (2000). Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia. Leukemia Research. 24(11). 957–963. 7 indexed citations

6.

Leblond, V., Éric Deconinck, A.-L. Taksin, et al.. (1998). Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.. Journal of Clinical Oncology. 16(6). 2060–2064. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact